Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from AstraZeneca

Vaccine caused Tas man's death: Coroner

A Tasmanian father of four died from adverse effects of the AstraZeneca coronavirus vaccine, a coroner has found.

AAP

Blood Clot Risk After First AstraZeneca COVID-19 Shot Very Small - UK Study Shows

A large study into rare blood clots linked with AstraZeneca Plc's (NASDAQ: AZN) COVID-19 vaccine found

Benzinga

Latest data shows AstraZeneca blood clot risk extremely small

The latest research indicates the risks of blood clots from AstraZeneca are extremely small, with data coming out from millions of people around the world who have had the COVID-19 vaccine.

The Canberra Times

From analysis to the latest developments in health,
read the most diverse news in one place.

AstraZeneca Gaps Higher After Touting 'Historic' And Unexpected Win In Breast Cancer

AstraZeneca popped to a three-month high after the company touted a previously unheard-of result for its breast cancer treatment, Enhertu.

Investors Business Daily

Roche And AstraZeneca Settle Ultomiris Patent Lawsuit

Roche Holdings AG (OTC: RHHBY) has decided to close out a patent infringement lawsuit against AstraZeneca plc (NASDAQ: AZN), centering around the latter's newly acquired rare disease drug Ultomiris for a

Benzinga

AstraZeneca's Stock Gain After Enhertu Meets Primary Endpoint In HER2-Low Breast Cancer Setting

AstraZeneca plc (NASDAQ: AZN) said that

Benzinga

Iran Returns Donated Vaccines Because They Were Made in US

Iran has returned 820,000 doses of coronavirus vaccines donated by Poland because they were manufactured in the United States, state TV reported Monday. TV quoted Mohammad Hashemi, an official in the country’s Health Ministry, as saying that Poland donated about a million doses of the British-Swedish AstraZeneca vaccine to Iran.…

Asharq Al-Awsat

Read news from The Economist, FT, and more,
with one subscription

AZ Covid jab professor reveals vile anti-vax attacks forced him to get police protection

Professor Andrew Pollard was a part of the team behind the Oxford-Astrazeneca Covid jab which saved untold lives, despite his work he received a number of threats from anti-vaxxers and extremists

Daily Mirror

Vaccine side effects very rare, says DDC

Few side effects have been reported among the 120 million Covid-19 vaccine doses administered, according to the Department of Disease Control (DDC).

Bangkok Post

Covid: South Korea reports more than 100,000 new cases for first time – as it happened

Latest updates: south Korean case numbers have risen in recent weeks due to Omicron

The Guardian - UK

Short Shelf Life Of AstraZeneca's COVID-19 Shot Entangles Vaccine Rollout In Poorer Nations: Reuters

According to officials and internal World Health Organization documents reviewed by Reuters, the relativel

Benzinga

Forget AstraZeneca, Buy These 4 Pharmaceutical Stocks Instead

Despite the rising demand for COVID-19 vaccines and other pharmaceutical products, AstraZeneca (AZN) has failed to deliver impressive earnings in its last quarter. While its recent drug launches are expected to do well in the long run, the consensus earnings estimate for the company in the current quarter indicates tepid…

StockNews.com

Exclusive-Short AstraZeneca shelf life complicates COVID vaccine rollout to world's poorest

Reuters

Germany and Switzerland set to ease restrictions – as it happened

This blog is now closed.

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Asharq Al-Awsat

Short AstraZeneca Shelf Life Complicates COVID Vaccine Rollout to World’s Poorest

The relatively short shelf life of AstraZeneca Plc's COVID-19 vaccine is complicating the rollout to the world's poorest nations, according to officials and internal World Health Organization documents reviewed by Reuters. It is the latest headache to plague the COVAX vaccine-sharing project, co-led by the WHO and aimed at getting…

Benzinga

Why Are AstraZeneca Shares Trading Higher Today

Adding AstraZeneca Plc's (NASDAQ: AZN) Lynparza to Johnson & Johnson's (NYSE: JNJ) Zytiga (abiraterone) extended the time to live without disease progression in patients with newly diagnosed

The Independent UK

Vaccinated people less likely to get long Covid than unvaccinated, new study shows

Review finds those who have received two doses of Pfizer/BioNTech, AstraZeneca or Moderna vaccine, or one dose of single-shot J&J vaccine, half as likely to develop long Covid symptoms

The Guardian - UK

UK pay growth lags behind inflation; company insolvencies rise – as it happened

Rolling coverage of the latest economic and financial news

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

AstraZeneca Stock Ranked No. 1 In Group; Recently Reported Record Sales, Strong Outlook

AstraZeneca recently reported record sales, and a bullish outlook. Its stock continues to idle though amid overall market weakness.

Birmingham Post

Software firm used by Coca-Cola, the UK Parliament and AstraZeneca acquired

Its clients also include Manchester Airports Group, Highways England and Unilever

Investors Business Daily

How An AstraZeneca Rivalry Led Seagen Stock To Crumble Despite A Sales Beat

Seagen offered a disappointing outlook for 2022 as AstraZeneca pressures its new breast cancer drug, leading SGEN stock to dive on Thursday.

Benzinga

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

AstraZeneca: Q4 Earnings Insights

AstraZeneca (NASDAQ:AZN) reported its Q4 earnings results on Thursday, February 10, 2022 at 02:15 AM. Here's what investors need to know about the announcement.

Benzinga

AstraZeneca Records Bumper COVID-19 Vaccine Sales Of ~$4B In FY21

AstraZeneca Plc's (NASDAQ: AZN) total revenue jumped 63% Y/Y to $12.0

The Guardian - UK

AstraZeneca forecasts higher 2022 sales after record revenues

Drugmaker’s total revenues increased by 41% last year with help from $4bn Covid jab income

1 … 18 19 20 21

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.